Dr. Donald McAlpine, MD
What this data tells you about Dr. McAlpine
Dr. Donald McAlpine is a pulmonary disease in Cape Coral, FL, with 20 years in practice. Based on federal Medicare data, Dr. McAlpine performed 4,226 Medicare services across 2,720 unique beneficiaries.
Between the years covered by Open Payments, Dr. McAlpine received a total of $15,575 from 57 pharmaceutical and/or device companies across 683 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McAlpine is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,650 | $94 | $264 |
| Hospital follow-up visit, moderate complexity | 434 | $65 | $165 |
| Test to determine lung volumes using gas dilution or washout | 335 | $33 | $89 |
| Test to examine how well the lungs exchange gases | 335 | $43 | $115 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 277 | $31 | $80 |
| Blood draw (venipuncture) | 152 | $8 | $17 |
| Initial hospital admission, moderate complexity | 92 | $107 | $273 |
| Comprehensive metabolic blood panel | 87 | $10 | $21 |
| Complete blood count (CBC) with differential | 85 | $8 | $16 |
| New patient office visit (45-59 min) | 82 | $129 | $347 |
| Office visit, established patient, complex (40-54 min) | 67 | $133 | $370 |
| Hospital follow-up visit, low complexity | 66 | $41 | $105 |
| Lipid panel (cholesterol and triglycerides) | 65 | $13 | $27 |
| Test to measure expiratory airflow and volume | 59 | $21 | $55 |
| Thyroid stimulating hormone (TSH) test | 57 | $16 | $34 |
| Office visit, established patient (20-29 min) | 46 | $66 | $187 |
| Hospital follow-up visit, high complexity | 44 | $97 | $248 |
| Hemoglobin A1c test (diabetes monitoring) | 33 | $10 | $19 |
| Free thyroxine (T4) test | 33 | $9 | $18 |
| Thyroid hormone, t3 measurement, free | 30 | $17 | $34 |
| Automated urinalysis | 26 | $2 | $4 |
| Test for exercise-induced lung stress | 26 | $26 | $69 |
| Urinalysis with microscopic exam | 22 | $3 | $6 |
| New patient office visit, complex (60-74 min) | 19 | $176 | $458 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 18 | $65 | $177 |
| Natriuretic peptide (heart and blood vessel protein) level | 17 | $38 | $79 |
| Initial hospital admission, high complexity | 17 | $142 | $362 |
| Vitamin B-12 level test | 15 | $15 | $30 |
| Biopsy of lung airway using an endoscope | 14 | $127 | $721 |
| Transitional care management services for problem of high complexity | 12 | $209 | $568 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 11 | $20 | $529 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McAlpine is a clinical cardiology specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (low-engagement, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McAlpine experienced with office visit, established patient (30-39 min)?
Does Dr. McAlpine receive payments from pharmaceutical companies?
How do Dr. McAlpine's costs compare to other pulmonary diseases in Cape Coral?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology